Bottom line
FPHAX vs FHLC: the short answer
FPHAX (Pharmaceuticals Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are quite different portfolios: only about 30% of their top holdings (by weight) are shared.
But FHLC is far broader, holding 337 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
FHLC is cheaper at 0.084% vs 0.67% — a difference of $59 a year per $10,000 invested.
Over five years, FPHAX returned +12.6% a year vs +7.2% for FHLC (reporting dates differ).
Updated Nov 19, 2026
FPHAX vs FHLC side by side
| FPHAX | FHLC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.67% | 0.084% |
| Annual cost per $10k | $67 | $8.4 |
| 10-yr cost on $10k (prospectus) | $835 | $108 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +30.3% | +2.6% |
| 5-yr return (annualized) | +12.6% | +7.2% |
| 10-yr return (annualized) | +10.0% | +8.8% |
| Best quarter | +18.5% | +16.4% |
| Worst quarter | −13.6% | −13.1% |
| Net assets (fund) | $1.5B | $3.3B |
| Number of holdings | 57 | 337 |
| Portfolio turnover | 77% | 3% |
| Returns as of | Apr 30, 2026 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FPHAX | FHLC | Difference |
|---|---|---|---|
| 2024 | +9.4% | +2.6% | +6.8% |
| 2023 | +12.5% | +2.5% | +10.0% |
| 2022 | +1.0% | −5.5% | +6.4% |
| 2021 | +11.8% | +20.4% | −8.5% |
| 2020 | +11.1% | +18.1% | −7.1% |
| 2019 | +31.6% | +21.9% | +9.7% |
| 2018 | +5.8% | +5.5% | +0.3% |
| 2017 | +10.7% | +23.3% | −12.6% |
| 2016 | −16.3% | −3.3% | −12.9% |
Source: Fund prospectus bar charts
Holdings overlap
4 of FPHAX's top 25 holdings also appear in FHLC's top 25.
| Holding | FPHAX | FHLC |
|---|---|---|
| ELI LILLY and CO | 28.78% | 13.35% |
| MERCK and CO INC | 4.74% | 4.66% |
| Gilead Sciences Inc | 3.97% | 2.34% |
| JOHNSON and JOHNSON | 3.77% | 8.93% |
Source: SEC Form N-PORT
FPHAX top 10
- ELI LILLY and CO — 28.78%
- Gsk Plc — 8.17%
- Viatris Inc — 5.45%
- Ucb Sa — 5.09%
- MERCK and CO INC — 4.74%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between FPHAX and FHLC?
Which is cheaper, FPHAX or FHLC?
Should I own both FPHAX and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.